Federal health officials are proposing changes to make sure medical devices that measure oxygen levels are working for patients of color. The Food and Drug Administration issued recommendations Monday ...
It’s not [fully] mature yet. ARANOTE, which was the last study [of an androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer ...
12 month transaction history compiled from ASX announcements. No sell transactions reported by Substantial Shareholders in the past 12 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback